Pinnacle Associates LTD Prothena Corp Public LTD CO Transaction History

Pinnacle Associates LTD

$7.08 Billion
Q4 2024

A detailed history of Pinnacle Associates LTD transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Pinnacle Associates LTD holds 103,081 shares of PRTA stock, worth $1.57 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

103,081

Previous 125,747 18.03%

Holding current value

$1.57 Million

Previous $2.1 Million 32.14%

% of portfolio

0.02%

Previous 0.03%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$11.95 - $18.35 $270,858 - $415,921	-22,666 Reduced 18.03%	103,081 $1.43 Million
Q3 2024 Oct 25, 2024	BUY	$16.73 - $24.79 $47,630 - $70,577	2,847 Added 2.32%	125,747 $2.1 Million
Q2 2024 Jul 30, 2024	SELL	$19.54 - $26.15 $46,192 - $61,818	-2,364 Reduced 1.89%	122,900 $2.54 Million
Q1 2024 Apr 26, 2024	SELL	$24.75 - $40.66 $11,954 - $19,638	-483 Reduced 0.38%	125,264 $3.1 Million
Q4 2023 Jan 19, 2024	BUY	$32.31 - $52.32 $23,941 - $38,769	741 Added 0.59%	125,747 $4.57 Million
Q3 2023 Oct 23, 2023	SELL	$47.3 - $70.6 $257,926 - $384,981	-5,453 Reduced 4.18%	125,006 $6.03 Million
Q2 2023 Jul 26, 2023	SELL	$48.26 - $78.59 $232,709 - $378,960	-4,822 Reduced 3.56%	130,459 $8.91 Million
Q1 2023 May 04, 2023	SELL	$46.97 - $58.27 $107,561 - $133,438	-2,290 Reduced 1.66%	135,281 $6.56 Million
Q4 2022 Jan 31, 2023	BUY	$52.05 - $65.0 $10,410 - $13,000	200 Added 0.15%	137,571 $8.29 Million
Q4 2022 Jan 25, 2023	SELL	$52.05 - $65.0 $141,836 - $177,125	-2,725 Reduced 1.95%	137,371 $0
Q3 2022 Oct 31, 2022	SELL	$25.16 - $60.63 $108,942 - $262,527	-4,330 Reduced 3.0%	140,096 $8.49 Million
Q2 2022 Aug 02, 2022	SELL	$22.73 - $39.98 $9,273 - $16,311	-408 Reduced 0.28%	144,426 $3.92 Million
Q1 2022 May 05, 2022	SELL	$30.27 - $49.22 $193,122 - $314,023	-6,380 Reduced 4.22%	144,834 $5.3 Million
Q4 2021 Feb 02, 2022	SELL	$42.11 - $73.26 $23,665 - $41,172	-562 Reduced 0.37%	151,214 $7.47 Million
Q3 2021 Oct 19, 2021	SELL	$48.2 - $78.89 $2.61 Million - $4.27 Million	-54,142 Reduced 26.29%	151,776 $10.8 Million
Q2 2021 Aug 02, 2021	SELL	$21.63 - $57.65 $1.59 Million - $4.25 Million	-73,642 Reduced 26.34%	205,918 $10.6 Million
Q1 2021 May 12, 2021	SELL	$11.0 - $28.24 $323,620 - $830,820	-29,420 Reduced 9.52%	279,560 $7.02 Million
Q4 2020 Jan 26, 2021	SELL	$10.12 - $13.94 $222,943 - $307,098	-22,030 Reduced 6.66%	308,980 $3.71 Million
Q3 2020 Oct 23, 2020	SELL	$9.93 - $13.47 $118,176 - $160,306	-11,901 Reduced 3.47%	331,010 $3.31 Million
Q2 2020 Aug 14, 2020	SELL	$9.56 - $12.51 $57,790 - $75,622	-6,045 Reduced 1.73%	342,911 $3.59 Million
Q1 2020 May 13, 2020	SELL	$7.54 - $15.77 $383,265 - $801,604	-50,831 Reduced 12.71%	348,956 $3.73 Million
Q4 2019 Feb 03, 2020	BUY	$7.48 - $17.01 $1.58 Million - $3.59 Million	211,319 Added 112.12%	399,787 $6.33 Million
Q3 2019 Nov 08, 2019	SELL	$6.89 - $10.45 $66,385 - $100,685	-9,635 Reduced 4.86%	188,468 $1.48 Million
Q2 2019 Aug 05, 2019	SELL	$8.85 - $12.49 $157,450 - $222,209	-17,791 Reduced 8.24%	198,103 $2.09 Million
Q1 2019 May 10, 2019	BUY	$10.32 - $14.49 $169,764 - $238,360	16,450 Added 8.25%	215,894 $2.62 Million
Q4 2018 Feb 05, 2019	SELL	$8.73 - $13.74 $334,498 - $526,461	-38,316 Reduced 16.12%	199,444 $2.05 Million
Q3 2018 Nov 13, 2018	SELL	$12.7 - $15.79 $473,189 - $588,319	-37,259 Reduced 13.55%	237,760 $3.11 Million
Q2 2018 Aug 08, 2018	SELL	$10.99 - $44.21 $503,946 - $2.03 Million	-45,855 Reduced 14.29%	275,019 $4.01 Million
Q1 2018 May 11, 2018	SELL	$27.95 - $45.04 $530,770 - $855,309	-18,990 Reduced 5.59%	320,874 $11.8 Million
Q4 2017 Feb 12, 2018	SELL	$35.44 - $63.76 $703,129 - $1.26 Million	-19,840 Reduced 5.52%	339,864 $12.7 Million
Q3 2017 Nov 13, 2017	SELL	$53.83 - $67.75 $518,329 - $652,364	-9,629 Reduced 2.61%	359,704 $23.3 Million
Q2 2017 Aug 09, 2017	BUY	N/A	369,333	369,333 $20 Million

Others Institutions Holding PRTA

# of Institutions

198

Shares Held

44.5M

Call Options Held

601K

Put Options Held

259K

View Full List

About PROTHENA CORP PUBLIC LTD CO

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $715M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

More about PRTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.

Account

Pinnacle Associates LTD Prothena Corp Public LTD CO Transaction History